The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intravenous Iron Infusion Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2029
Synopsis
The global Intravenous Iron Infusion market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
Intravenous Iron Infusion can quickly provide a large amount of iron to directly enter the circulatory system, thereby promoting the production of red blood cells and repairing the symptoms of anemia caused by iron deficiency. This treatment is usually administered by a doctor in a medical facility or clinic, with the dose and frequency of injections determined according to the patient's specific situation and needs.
The Global Info Research report includes an overview of the development of the Intravenous Iron Infusion industry chain, the market status of Gastroenterology (Ferric Carboxymaltose, Iron Sucrose), Oncology (Ferric Carboxymaltose, Iron Sucrose), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Intravenous Iron Infusion.
Regionally, the report analyzes the Intravenous Iron Infusion markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Intravenous Iron Infusion market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Intravenous Iron Infusion market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Intravenous Iron Infusion industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Ferric Carboxymaltose, Iron Sucrose).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Intravenous Iron Infusion market.
Regional Analysis: The report involves examining the Intravenous Iron Infusion market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Intravenous Iron Infusion market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Intravenous Iron Infusion:
Company Analysis: Report covers individual Intravenous Iron Infusion manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Intravenous Iron Infusion This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Gastroenterology, Oncology).
Technology Analysis: Report covers specific technologies relevant to Intravenous Iron Infusion. It assesses the current state, advancements, and potential future developments in Intravenous Iron Infusion areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Intravenous Iron Infusion market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Intravenous Iron Infusion market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Ferric Carboxymaltose
Iron Sucrose
Iron Dextran
Iron Isomaltosid
Others
Market segment by Application
Gastroenterology
Oncology
Cardiology
Others
Major players covered
Allergan
AMAG Pharmaceuticals
Daiichi Sankyo
Vifor (International)
Pharmacosmos
Nippon Shinyaku
Sanofi
AbbVie
Fresenius Kabi
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intravenous Iron Infusion product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intravenous Iron Infusion, with price, sales, revenue and global market share of Intravenous Iron Infusion from 2018 to 2023.
Chapter 3, the Intravenous Iron Infusion competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravenous Iron Infusion breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Intravenous Iron Infusion market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intravenous Iron Infusion.
Chapter 14 and 15, to describe Intravenous Iron Infusion sales channel, distributors, customers, research findings and conclusion.
The global Intravenous Iron Infusion market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
Intravenous Iron Infusion can quickly provide a large amount of iron to directly enter the circulatory system, thereby promoting the production of red blood cells and repairing the symptoms of anemia caused by iron deficiency. This treatment is usually administered by a doctor in a medical facility or clinic, with the dose and frequency of injections determined according to the patient's specific situation and needs.
The Global Info Research report includes an overview of the development of the Intravenous Iron Infusion industry chain, the market status of Gastroenterology (Ferric Carboxymaltose, Iron Sucrose), Oncology (Ferric Carboxymaltose, Iron Sucrose), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Intravenous Iron Infusion.
Regionally, the report analyzes the Intravenous Iron Infusion markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Intravenous Iron Infusion market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Intravenous Iron Infusion market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Intravenous Iron Infusion industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Ferric Carboxymaltose, Iron Sucrose).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Intravenous Iron Infusion market.
Regional Analysis: The report involves examining the Intravenous Iron Infusion market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Intravenous Iron Infusion market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Intravenous Iron Infusion:
Company Analysis: Report covers individual Intravenous Iron Infusion manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Intravenous Iron Infusion This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Gastroenterology, Oncology).
Technology Analysis: Report covers specific technologies relevant to Intravenous Iron Infusion. It assesses the current state, advancements, and potential future developments in Intravenous Iron Infusion areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Intravenous Iron Infusion market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Intravenous Iron Infusion market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Ferric Carboxymaltose
Iron Sucrose
Iron Dextran
Iron Isomaltosid
Others
Market segment by Application
Gastroenterology
Oncology
Cardiology
Others
Major players covered
Allergan
AMAG Pharmaceuticals
Daiichi Sankyo
Vifor (International)
Pharmacosmos
Nippon Shinyaku
Sanofi
AbbVie
Fresenius Kabi
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intravenous Iron Infusion product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intravenous Iron Infusion, with price, sales, revenue and global market share of Intravenous Iron Infusion from 2018 to 2023.
Chapter 3, the Intravenous Iron Infusion competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravenous Iron Infusion breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Intravenous Iron Infusion market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intravenous Iron Infusion.
Chapter 14 and 15, to describe Intravenous Iron Infusion sales channel, distributors, customers, research findings and conclusion.
Index1 Market Overview
1.1 Product Overview and Scope of Intravenous Iron Infusion
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Intravenous Iron Infusion Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Ferric Carboxymaltose
1.3.3 Iron Sucrose
1.3.4 Iron Dextran
1.3.5 Iron Isomaltosid
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Intravenous Iron Infusion Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Gastroenterology
1.4.3 Oncology
1.4.4 Cardiology
1.4.5 Others
1.5 Global Intravenous Iron Infusion Market Size & Forecast
1.5.1 Global Intravenous Iron Infusion Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Intravenous Iron Infusion Sales Quantity (2018-2029)
1.5.3 Global Intravenous Iron Infusion Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business
2.1.3 Allergan Intravenous Iron Infusion Product and Services
2.1.4 Allergan Intravenous Iron Infusion Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Allergan Recent Developments/Updates
2.2 AMAG Pharmaceuticals
2.2.1 AMAG Pharmaceuticals Details
2.2.2 AMAG Pharmaceuticals Major Business
2.2.3 AMAG Pharmaceuticals Intravenous Iron Infusion Product and Services
2.2.4 AMAG Pharmaceuticals Intravenous Iron Infusion Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AMAG Pharmaceuticals Recent Developments/Updates
2.3 Daiichi Sankyo
2.3.1 Daiichi Sankyo Details
2.3.2 Daiichi Sankyo Major Business
2.3.3 Daiichi Sankyo Intravenous Iron Infusion Product and Services
2.3.4 Daiichi Sankyo Intravenous Iron Infusion Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Daiichi Sankyo Recent Developments/Updates
2.4 Vifor (International)
2.4.1 Vifor (International) Details
2.4.2 Vifor (International) Major Business
2.4.3 Vifor (International) Intravenous Iron Infusion Product and Services
2.4.4 Vifor (International) Intravenous Iron Infusion Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Vifor (International) Recent Developments/Updates
2.5 Pharmacosmos
2.5.1 Pharmacosmos Details
2.5.2 Pharmacosmos Major Business
2.5.3 Pharmacosmos Intravenous Iron Infusion Product and Services
2.5.4 Pharmacosmos Intravenous Iron Infusion Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Pharmacosmos Recent Developments/Updates
2.6 Nippon Shinyaku
2.6.1 Nippon Shinyaku Details
2.6.2 Nippon Shinyaku Major Business
2.6.3 Nippon Shinyaku Intravenous Iron Infusion Product and Services
2.6.4 Nippon Shinyaku Intravenous Iron Infusion Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Nippon Shinyaku Recent Developments/Updates
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Intravenous Iron Infusion Product and Services
2.7.4 Sanofi Intravenous Iron Infusion Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Sanofi Recent Developments/Updates
2.8 AbbVie
2.8.1 AbbVie Details
2.8.2 AbbVie Major Business
2.8.3 AbbVie Intravenous Iron Infusion Product and Services
2.8.4 AbbVie Intravenous Iron Infusion Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 AbbVie Recent Developments/Updates
2.9 Fresenius Kabi
2.9.1 Fresenius Kabi Details
2.9.2 Fresenius Kabi Major Business
2.9.3 Fresenius Kabi Intravenous Iron Infusion Product and Services
2.9.4 Fresenius Kabi Intravenous Iron Infusion Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Fresenius Kabi Recent Developments/Updates
3 Competitive Environment: Intravenous Iron Infusion by Manufacturer
3.1 Global Intravenous Iron Infusion Sales Quantity by Manufacturer (2018-2023)
3.2 Global Intravenous Iron Infusion Revenue by Manufacturer (2018-2023)
3.3 Global Intravenous Iron Infusion Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Intravenous Iron Infusion by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Intravenous Iron Infusion Manufacturer Market Share in 2022
3.4.2 Top 6 Intravenous Iron Infusion Manufacturer Market Share in 2022
3.5 Intravenous Iron Infusion Market: Overall Company Footprint Analysis
3.5.1 Intravenous Iron Infusion Market: Region Footprint
3.5.2 Intravenous Iron Infusion Market: Company Product Type Footprint
3.5.3 Intravenous Iron Infusion Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Intravenous Iron Infusion Market Size by Region
4.1.1 Global Intravenous Iron Infusion Sales Quantity by Region (2018-2029)
4.1.2 Global Intravenous Iron Infusion Consumption Value by Region (2018-2029)
4.1.3 Global Intravenous Iron Infusion Average Price by Region (2018-2029)
4.2 North America Intravenous Iron Infusion Consumption Value (2018-2029)
4.3 Europe Intravenous Iron Infusion Consumption Value (2018-2029)
4.4 Asia-Pacific Intravenous Iron Infusion Consumption Value (2018-2029)
4.5 South America Intravenous Iron Infusion Consumption Value (2018-2029)
4.6 Middle East and Africa Intravenous Iron Infusion Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Intravenous Iron Infusion Sales Quantity by Type (2018-2029)
5.2 Global Intravenous Iron Infusion Consumption Value by Type (2018-2029)
5.3 Global Intravenous Iron Infusion Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Intravenous Iron Infusion Sales Quantity by Application (2018-2029)
6.2 Global Intravenous Iron Infusion Consumption Value by Application (2018-2029)
6.3 Global Intravenous Iron Infusion Average Price by Application (2018-2029)
7 North America
7.1 North America Intravenous Iron Infusion Sales Quantity by Type (2018-2029)
7.2 North America Intravenous Iron Infusion Sales Quantity by Application (2018-2029)
7.3 North America Intravenous Iron Infusion Market Size by Country
7.3.1 North America Intravenous Iron Infusion Sales Quantity by Country (2018-2029)
7.3.2 North America Intravenous Iron Infusion Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Intravenous Iron Infusion Sales Quantity by Type (2018-2029)
8.2 Europe Intravenous Iron Infusion Sales Quantity by Application (2018-2029)
8.3 Europe Intravenous Iron Infusion Market Size by Country
8.3.1 Europe Intravenous Iron Infusion Sales Quantity by Country (2018-2029)
8.3.2 Europe Intravenous Iron Infusion Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Intravenous Iron Infusion Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Intravenous Iron Infusion Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Intravenous Iron Infusion Market Size by Region
9.3.1 Asia-Pacific Intravenous Iron Infusion Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Intravenous Iron Infusion Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Intravenous Iron Infusion Sales Quantity by Type (2018-2029)
10.2 South America Intravenous Iron Infusion Sales Quantity by Application (2018-2029)
10.3 South America Intravenous Iron Infusion Market Size by Country
10.3.1 South America Intravenous Iron Infusion Sales Quantity by Country (2018-2029)
10.3.2 South America Intravenous Iron Infusion Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Intravenous Iron Infusion Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Intravenous Iron Infusion Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Intravenous Iron Infusion Market Size by Country
11.3.1 Middle East & Africa Intravenous Iron Infusion Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Intravenous Iron Infusion Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Intravenous Iron Infusion Market Drivers
12.2 Intravenous Iron Infusion Market Restraints
12.3 Intravenous Iron Infusion Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Intravenous Iron Infusion and Key Manufacturers
13.2 Manufacturing Costs Percentage of Intravenous Iron Infusion
13.3 Intravenous Iron Infusion Production Process
13.4 Intravenous Iron Infusion Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Intravenous Iron Infusion Typical Distributors
14.3 Intravenous Iron Infusion Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
